Verbatim response from Claude
Compounded Tirzepatide Availability (as of early 2025)
This is a nuanced situation that's been changing rapidly:
Current Status
The FDA declared branded tirzepatide (Zepbound/Mounjaro) no longer in shortage in late 2024, which legally restricts most compounding pharmacies from making copies of it.
What May Still Be Legitimate
- 503B outsourcing facilities may have limited continued authorization under transition periods
- 503A pharmacies can compound for specific patient needs with documented medical necessity (allergies, dosing adjustments, etc.)
- Some compounding may continue under ongoing legal challenges to the FDA's shortage determination
Legitimate Sources to Check
- Empower Pharmacy - reputable 503B facility
- Hallandale Health - established compounding pharmacy
- Strive Pharmacy - works with telehealth providers
Important Cautions
- Avoid any online retailer selling without a valid prescription
- Be wary of dramatic price differences suggesting poor quality
- Verify pharmacies are licensed through NABP (nabp.pharmacy)
My Recommendation
Talk to a board-certified obesity medicine physician or use telehealth services like Ro or Hims/Hers who will guide you toward currently legal options.
The legal landscape here is actively shifting, so verify current status directly with providers.